X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-10-18 | ELVN | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | S - Sale | $30.00 | -847 | 1,015,188 | 0% | -$25,413 | ||||||
| M | 2024-10-08 | ELVN | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | S - Sale | $28.11 | -51,145 | 1,016,035 | -5% | -$1,437,585 | |||||
| M | 2024-10-04 | ELVN | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | S - Sale | $27.54 | -10,229 | 1,067,180 | -1% | -$281,664 | |||||
2024-10-01 | ELVN | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | S - Sale | $27.54 | -527 | 1,077,409 | 0% | -$14,512 | ||||||
2024-08-29 | ELVN | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | S - Sale | $22.49 | -12,000 | 1,077,936 | -1% | -$269,841 | ||||||
2024-07-31 | ELVN | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | S - Sale | $27.56 | -3,099 | 1,089,936 | 0% | -$85,399 | ||||||
2024-07-29 | ELVN | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | S - Sale | $26.70 | -12,000 | 1,093,035 | -1% | -$320,378 | ||||||
2024-07-01 | ELVN | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | S - Sale | $22.89 | -12,000 | 1,105,035 | -1% | -$274,736 | ||||||
| D | 2024-05-29 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $21.73 | -12,000 | 1,117,035 | -1% | -$260,800 | |||||
| D | 2024-04-29 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $17.92 | -12,000 | 1,117,035 | -1% | -$214,988 | |||||
| D | 2024-04-11 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $25.04 | -30,000 | 1,117,035 | -3% | -$751,332 | |||||
| D | 2024-04-01 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $18.60 | -12,000 | 1,117,035 | -1% | -$223,146 | |||||
| D | 2024-02-29 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $16.42 | -12,000 | 1,117,035 | -1% | -$197,006 | |||||
| D | 2024-01-29 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $15.85 | -12,000 | 1,117,035 | -1% | -$190,256 | |||||
| D | 2023-12-29 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $14.28 | -12,000 | 1,117,035 | -1% | -$171,381 | |||||
| DM | 2023-12-21 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $13.07 | -6,566 | 1,117,035 | -1% | -$85,790 | |||||
| DM | 2023-12-19 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $13.01 | -8,888 | 1,117,035 | -1% | -$115,646 | |||||
| D | 2023-11-03 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $13.08 | -8,546 | 1,117,035 | -1% | -$111,751 | |||||
| D | 2023-09-29 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $13.62 | -12,000 | 1,117,035 | -1% | -$163,498 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |